Dimensional Fund Advisors’s Anavex Life Sciences AVXL Stock Holding History

Dimensional Fund Advisors’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$70.5K	Hold	27,238	–	–	﹤0.01%	3165
2026 Q1	$83.6K	Buy	27,238 +6	+0%	+$26	﹤0.01%	3134
2025 Q4	$96.9K	Buy	+27,232	New	+$167K	﹤0.01%	3151
2025 Q3	–	Sell	-45,899	Closed	-$423K	–	3278
2025 Q2	$423K	Hold	45,899	–	–	﹤0.01%	3018
2025 Q1	$394K	Sell	45,899 -3,697	-7%	-$34.9K	﹤0.01%	3028
2024 Q4	$533K	Hold	49,596	–	–	﹤0.01%	3024
2024 Q3	$282K	Hold	49,596	–	–	﹤0.01%	3118
2024 Q2	$209K	Hold	49,596	–	–	﹤0.01%	3156
2024 Q1	$252K	Hold	49,596	–	–	﹤0.01%	3156
2023 Q4	$462K	Buy	+49,596	New	+$341K	﹤0.01%	3052
2019 Q2	–	Sell	-10,469	Closed	-$32K	–	3465
2019 Q1	$32K	Hold	10,469	–	–	﹤0.01%	3425
2018 Q4	$16K	Hold	10,469	–	–	﹤0.01%	3438
2018 Q3	$29K	Buy	+10,469	New	+$29.5K	﹤0.01%	3408

Other funds holding AVXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dimensional Fund Advisors's AVXL Position: Q2 2026 in Review

Dimensional Fund Advisors held its Anavex Life Sciences (AVXL) position steady in Q2 2026 at 27,238 shares worth $70.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3165.

Dimensional Fund Advisors first reported a position in AVXL in Q3 2018 and has held it in 13 quarters since. The position peaked at $533K in Q4 2024. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

Dimensional Fund Advisors held 27,238 shares of Anavex Life Sciences worth $70.5K as of Q2 2026.
Dimensional Fund Advisors left its Anavex Life Sciences share count unchanged in Q2 2026.
Anavex Life Sciences made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #3165 holding.
Dimensional Fund Advisors first reported a position in Anavex Life Sciences in Q3 2018 and has held it in 13 quarters since.
Dimensional Fund Advisors's Anavex Life Sciences position peaked at $533K in Q4 2024.
179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.